ERCC2 and melanoma: In fact, subjects with dysplastic naevi had higher relative odds for melanoma, but they did not significantly vary by XPD status: when compared with subjects without dysplastic naevi and with the 751Lys/Lys genotype, individuals with dysplastic naevi and the 751Lys/Lys genotype had OR=10.9 (95% CI=3.6–33.7); those with dysplastic naevi and either the 751Gln/Lys or 751Gln/Gln genotype had OR=6.7 (95% CI=2.4–18.2).